Article

Americans: Don't Weigh Costs of New Treatments

Most Americans don't want the government to decide if medical treatments are economical before letting patients use them, a new survey suggests.

Most Americans don't want the government to decide if medical treatments are economical before letting patients use them, a new survey suggests.

In some places, such as the UK and Germany, governments do have that power. Before patients can use a new drug, for instance, the government studies how well it works. It also sees what the drug costs compared to other drugs before deciding to make it available.

"The idea is to say, if we add this new technology, are we getting enough value for it given the increase in what we have to pay?" said Michael Botta. Botta led the study while in Harvard University's Program in Health Policy in Cambridge, Massachusetts.

Read the full story here: http://reut.rs/17h3pe5

Source: Reuters

Related Videos
Screenshot of Adam Colborn, JD during an interview
dr ian neeland
Crystal S. Denlinger, MD, FACP, CEO of the National Comprehensive Cancer Network
Kimberly Westrich, MA, chief strategy officer of the National Pharmaceutical Council
Phaedra Corso, PhD, associate vice president for research at Indiana University
Julie Patterson, PharmD, PhD
Nancy Dreyer, MPH, PhD, FISE, chief scientific advisor to Picnic Health
Seth Berkowitz, MD, MPH, associate professor of medicine, University of North Carolina at Chapel Hill
Related Content
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo